Thus, we assessed the effect of STAT1 blockage on anti-PD-1 efficacy in the context of B16-F10 melanoma-bearing mice, thereby elucidating whether STAT1 is associated with immunotherapy resistance. The gene discussed is STAT1; the disease is melanoma.